Latest Glioma Stories
In a first-of-its-kind experiment using microvesicles generated from mesenchymal bone marrow cells (MSCs) to treat cancer, neurological researchers at Henry Ford Hospital have discovered a novel approach for treatment of tumors. Specifically, the research team found that introducing genetic material produced by MSCs significantly reduced a particularly resistant form of malignant brain tumor in living lab rats. Detroit, Michigan (PRWEB) April 01, 2013 DETROIT – In a first-of-its-kind...
-- Genomic, Molecular Findings by CHOP Researchers Will Help Inform Personalized Medicine -- PHILADELPHIA, March 26, 2013 /PRNewswire-USNewswire/ -- Pediatric researchers, investigating the biology of brain tumors in children, are finding that crucial differences in how the same gene is mutated may call for different treatments. A new study offers glimpses into how scientists will be using the ongoing flood of gene-sequencing data to customize treatments based on very specific...
Louis and Phyllis Jacobs Honored for Commitment to Brain Tumor Patients and the ABTA Chicago, IL (PRWEB) March 22, 2013 The American Brain Tumor Association (ABTA) has named Louis and Phyllis Jacobs as the recipients of the 2013 Joel A. Gingras, Jr. Award. For the past 14 years, the Jacobs have supported brain tumor patients and families in their community, as well as supported the ABTA’s brain tumor research funding initiatives. The Joel A. Gingras, Jr. Award is given annually to an...
Booke & Co. to Provide Investor Relations Counsel VANCOUVER, British Columbia and MENLO PARK, Calif., March 7, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the completion of a $10.5 million private placement. Charles Vista, LLC acted as the company's placement agent in the unit offering. Each unit consists of one share of common stock and one common stock purchase warrant. The maximum offering in the Private Placement consisted of...
Scientists at Duke and Johns Hopkins found mutations in two genes that could become therapeutic targets in malignant glioma. Could this be the research breakthrough in the type of pediatric brain stem tumor that children must face? (PRWEB) March 05, 2013 The Rory David Deutsch Foundation wants you to know that there are many “heroes” in the fight to eradicate pediatric brain cancer. The children at the center of the battle lead the way. The scientists who put in long hours of research...
GAITHERSBURG, Md., Feb. 13, 2013 /PRNewswire/ -- Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells (product name: LG631-CD34) for bone marrow protection in the treatment of glioblastoma multiforme. Orphan drug designation...
Voices Against Brain Cancer responds to an article that reports on new research suggesting that a more focused form of radiation treatment can be more effective for treating brain tumors. New York, NY (PRWEB) January 26, 2013 On January 26, Voices Against Brain Cancer (VABC) responds to a recent article published by Health.com regarding a new form of radiation treatment that has the potential to be a more effective tool in the fight against brain cancer. New research suggests that the use...
Dr. Weiran Tang is the newly named Director of the Tumor Immunology Laboratory at Puhua International Hospitals-Temple of Heaven, Beijing, China. Beijing, China (PRWEB) (PRWEB) January 20, 2013 Puhua International Hospitals (PIH)-Temple of Heaven (http://www.puhuachina.com) has been a leading international hospital in Beijing, China, for the past 20 years. During that time PIH has maintained a dominant presence in Beijing, China in neurology, neurosurgery and related areas of medicine and...
Purdue University A new tool that could allow for faster, more comprehensive testing of brain tissue during surgery successfully identified the cancer type, grade and tumor margins in five brain surgery patients, according to a Purdue University and Brigham and Women's Hospital study. The tool sprays a microscopic stream of charged solvent onto the tissue surface to gather information about its molecular makeup and produces a color-coded image that reveals the nature and concentration...
VANCOUVER, British Columbia, Jan. 7, 2013 /PRNewswire/ -- Del Mar Pharma today announced that the European Committee for Orphan Medicinal Products (COMP) has recommended the designation of VAL-083 as an orphan medicinal product for the treatment of glioma. The COMP recommendation will be ratified by the European Commission in accordance with Article 5(8) of Regulation (EC) No. 141/2000. Glioma is a type of tumor that starts in the brain or spine and includes glioblastoma multiforme...
